The critical importance of early omnichannel engagement for pharma launch success


By Ben Harbour, expert-trainer of Omnichannel Launch Excellence for Medical & Marketing  
 

Pharma launches are often won or lost long before approval. Yet most organizations over-focus on the final 12 months. Evidence shows only 47% of companies start digital engagement early, despite clear advantages for those that do.

The Critical Importance of Early Omnichannel Engagement for Pharma Launch Success

 

Why early engagement is essential
 

  • Trust is built early 🤝

    HCPs expect evidence before promotion. Early KOL engagement and data-driven education secure credibility long before launch.

  • Awareness takes time ⏳

    Disease education, biomarker testing, and infrastructure readiness cannot be rushed. Starting 24–48 months ahead allows enough lead-in.

  • Competition won’t wait ⚡

    The first mover sets the narrative. If competitors shape the discussion early, you risk playing catch-up at launch.
     

What “early” looks like
 

  • Pre-Launch (T-48–24 months):

    Collect insights, build the evidence base, establish disease awareness campaigns, and engage advocacy groups.

  • Peri-Launch (T-24–12 months):

    Segment and prioritize customers, co-create educational content, test digital channels, and refine value messaging.

  • Launch (T-12–0 months):

    Execute integrated omnichannel campaigns across personal and non-personal channels, using predictive KPIs to monitor readiness.
     

How Medical Affairs and Commercial make “early” work
 

Medical Affairs đź’Š

  • Lead with evidence and unmet need education.
  • Strengthen credibility through early scientific exchange.
  • Ensure cross-functional alignment.
     

Marketing 📢

  • Build anticipation with awareness-first messaging.
  • Pilot channels and refine customer journeys early.
  • Prepare audiences for adoption at launch.


👉 Launch excellence doesn’t start at launch. It starts years earlier, with Medical and Marketing working hand-in-hand to build awareness, trust, and adoption through early omnichannel engagement.
 

 

 

Subscribe to CELforPharma's newsletter to receive tips & insights from our expert faculty:

 

Please indicate your domains of interest:

Interested in domains

By subscribing to this newsletter, I accept the Privacy Policy.